These results indicate that serum E.CPS antibody titer reflects liver cirrhosis progression, while serum LBP, Mac-2 bp, AAL-Hp and ALBI scores can be used to monitor the progression of liver diseases. This evidence concerns the gene LBP and liver disorder.